Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva

Mostrar otras versiones (1)

Vaccines are critical for curtailing the COVID-19 pandemic (1, 2). In the USA, two highly protective mRNA vaccines are available: BNT162b2 from Pfizer/BioNTech and mRNA-1273 from Moderna (3, 4). These vaccines induce antibodies to the SARS-CoV-2 S-protein, including neutralizing antibodies (NAbs) pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketas, Thomas J., Chaturbhuj, Devidas, Cruz-Portillo, Victor M, Francomano, Erik, Golden, Encouse, Chandrasekhar, Sharanya, Debnath, Gargi, Diaz-Tapia, Randy, Yasmeen, Anila, Leconet, Wilhem, Zhao, Zhen, Brouwer, Philip J.M., Cushing, Melissa M., Sanders, Rogier W., Cupo, Albert, Klasse, P. J., Formenti, Silvia C., Moore, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987001/
https://www.ncbi.nlm.nih.gov/pubmed/33758842
http://dx.doi.org/10.1101/2021.03.11.434841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987001/
https://www.ncbi.nlm.nih.gov/pubmed/33758842
http://dx.doi.org/10.1101/2021.03.11.434841

Ejemplares similares